Financial instruments (Details 4)
$ in Millions |
6 Months Ended |
|
Jun. 30, 2020
USD ($)
|
|---|
| Novartis Capital Corporation, New York, United States, 1.75%, 2025 [member] |
|
| Disclosure of detailed information about borrowings [line items] |
|
| Borrowings, coupon |
1.75%
|
| Borrowings, original currency |
USD
|
| Notional amount |
$ 1,000
|
| Borrowings, maturity year |
2025
|
| Borrowings, issuer |
Novartis Capital Corporation, New York, United States
|
| Borrowings, issue price |
99.852%
|
| Straight bonds |
$ 996
|
| Novartis Capital Corporation, New York, United States, 2.00%, 2027 [member] |
|
| Disclosure of detailed information about borrowings [line items] |
|
| Borrowings, coupon |
2.00%
|
| Borrowings, original currency |
USD
|
| Notional amount |
$ 1,250
|
| Borrowings, maturity year |
2027
|
| Borrowings, issuer |
Novartis Capital Corporation, New York, United States
|
| Borrowings, issue price |
99.909%
|
| Straight bonds |
$ 1,245
|
| Novartis Capital Corporation, New York, United States, 2.20%, 2030 [member] |
|
| Disclosure of detailed information about borrowings [line items] |
|
| Borrowings, coupon |
2.20%
|
| Borrowings, original currency |
USD
|
| Notional amount |
$ 1,500
|
| Borrowings, maturity year |
2030
|
| Borrowings, issuer |
Novartis Capital Corporation, New York, United States
|
| Borrowings, issue price |
99.869%
|
| Straight bonds |
$ 1,492
|
| Novartis Capital Corporation, New York, United States, 2.75%, 2050 [member] |
|
| Disclosure of detailed information about borrowings [line items] |
|
| Borrowings, coupon |
2.75%
|
| Borrowings, original currency |
USD
|
| Notional amount |
$ 1,250
|
| Borrowings, maturity year |
2050
|
| Borrowings, issuer |
Novartis Capital Corporation, New York, United States
|
| Borrowings, issue price |
97.712%
|
| Straight bonds |
$ 1,213
|